Cargando…
A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer
IMPORTANCE: Treatment of resectable gastric cancer (RGC) uses a multimodal approach, including surgical treatment and chemotherapy with or without radiation therapy, and the optimal treatment strategy and timing of each of these modalities is unknown. OBJECTIVE: To investigate the association of var...
Autores principales: | Anderson, Eric, LeVee, Alexis, Kim, Sungjin, Atkins, Katelyn, Guan, Michelle, Placencio-Hickok, Veronica, Moshayedi, Natalie, Hendifar, Andrew, Osipov, Arsen, Gangi, Alexandra, Burch, Miguel, Waters, Kevin, Cho, May, Klempner, Samuel, Chao, Joseph, Kamrava, Mitchell, Gong, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665367/ https://www.ncbi.nlm.nih.gov/pubmed/34889947 http://dx.doi.org/10.1001/jamanetworkopen.2021.38432 |
Ejemplares similares
-
Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer
por: Midthun, Lauren, et al.
Publicado: (2022) -
Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy
por: Kim, Sungjin, et al.
Publicado: (2020) -
Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers
por: Chuang, Jeremy, et al.
Publicado: (2022) -
Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer
por: Muranaka, Hayato, et al.
Publicado: (2023) -
Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers
por: David, John M., et al.
Publicado: (2018)